Records containing: Tumors
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-11-07A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AMG 337 in Adult Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2022-11-07Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated Intensity Modulated Radiotherapy (IMRT) in Treatment of Breast Cancer: The KOSIMA Trial
-
CLINICAL_TRIALS study record update · 2022-10-21Observational Post-Market Study of the XACT ACE Robotic System
-
CLINICAL_TRIALS study record update · 2022-09-23Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2022-08-22Research on the Application and Mechanism of New Biological Probes in Biomedicine
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-07-22Kypho-IORT: Phase II Study for Dose Escalation of Intraoperative Radiotherapy During Kyphoplasty for Spinal Metastases
-
CLINICAL_TRIALS study record update · 2022-05-16A Phase I/II Study of NB1011 Administered Intravenously by Continuous Infusion in an Every Second Week Regimen With Open-label Continuation in Cancers That Overexpress the Enzyme Thymidylate Synthase
-
CLINICAL_TRIALS study record update · 2022-05-02A Phase I Clinical Study of L-001079038 in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2021-11-26A Phase I Study Using Vaccination With NY-ESO-1 Recombinant Protein Mixed With CpG 7909 and Montanide ISA-51 VG in Patients With Cancers That Often Express NY-ESO-1.
-
CLINICAL_TRIALS study record update · 2021-11-10A Phase 2, Open-Label, Single-Arm, Multicenter Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors
-
CLINICAL_TRIALS study record update · 2021-09-29Phase III Study for Analysis of the Optimal Application Dose of Superficial Hyperthermia
-
CLINICAL_TRIALS study record update · 2021-09-02A Phase 1 First-in-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 232 in Adult Subjects With Advanced Solid Tumors or Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2021-06-04An Open-Label, Multicohort, Phase II Study of Atezolizumab in Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2021-05-12A Phase I/II Safety, Pharmacokinetic, and Pharmacodynamic Study of APS001F With Flucytosine and Maltose for the Treatment of Advanced and/or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2021-03-26A Phase 1b/2a Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 232 Combined With Trametinib and Dabrafenib or Trametinib in Adult Subjects With Metastatic Cutaneous Melanoma
-
CLINICAL_TRIALS study record update · 2021-02-17A Phase 1, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-12-22A Phase 1 With Expansion Cohort, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Intravenously Infused IT-141 in Subjects With Recurrent or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-12-21A Randomized, Open-label, Multi-center, Phase I, Crossover Study to Assess the Relative Bioavailability of 2 Oral Formulations of TKI258, and the Effect of Food on the Bioavailability of TKI258, in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-12-21A Randomized, Open-label, Multi-center, Phase I, Crossover Study to Assess the Relative Bioavailability of 2 Oral Formulations of TKI258 (CSF Capsule vs. FMI Tablet), and the Effect of Food on the Bioavailability of TKI258, in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-12-09An Open-label, Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function
-
CLINICAL_TRIALS study record update · 2020-09-17Phase 1/2 Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma
-
CLINICAL_TRIALS study record update · 2020-07-30A Phase I, Open-label, Dose-escalation Study to Determine the Maximum Tolerance Dose (MTD) and to Evaluate the Safety of 188Re-BMEDA-liposome in Patient With Primary Solid Tumor in Advanced or Metastatic Stage.
-
CLINICAL_TRIALS study record update · 2020-06-05Magnetic Resonance Imaging at 1.5 and 3.0 Tesla
-
CLINICAL_TRIALS study record update · 2020-04-24Retreatment of Recurrent Tumors Using Proton Therapy
-
CLINICAL_TRIALS study record update · 2020-02-17An Open-Label Multicenter Phase 1 Study of E7046 in Subjects With Selected Advanced Malignancies